Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 701 clients, with 2,757 partnered brands and 632 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
DAIICHI-SANKYO ALDAY Clinical Trial Name
DAIICHI-SANKYO AZOR Cardiovascular
DAIICHI-SANKYO BENICAR * Cardiovascular
DAIICHI-SANKYO BENICAR HCT * Cardiovascular
DAIICHI-SANKYO EFFIENT Cardiovascular
DAIICHI-SANKYO EFIENT (エフィエント) Cardiovascular
DAIICHI-SANKYO ENGAGE AF Clinical Trial Name
DAIICHI-SANKYO firuglipel Endocrinology
DAIICHI-SANKYO FLOXIN OTIC Antibiotic
DAIICHI-SANKYO FLOXIN OTIC SINGLES * Antibiotic
DAIICHI-SANKYO LIXIANA Cardiovascular
DAIICHI-SANKYO milademetan Oncology
DAIICHI-SANKYO MOBIC Pain & Inflammation
DAIICHI-SANKYO NEUCOURSE Clinical Trial Name
DAIICHI-SANKYO patritumab Oncology
DAIICHI-SANKYO pexidartinib Oncology
DAIICHI-SANKYO PRASFIT Clinical Trial Name
DAIICHI-SANKYO PRASTRO Clinical Trial Name
DAIICHI-SANKYO QUIXIN * Ophthalmology
DAIICHI-SANKYO REDUCER Clinical Trial Name
DAIICHI-SANKYO REZALTAS Cardiovascular
DAIICHI-SANKYO ROTEAS Cardiovascular
DAIICHI-SANKYO SAVAYSA * Cardiovascular
DAIICHI-SANKYO SEVIKAR Cardiovascular
DAIICHI-SANKYO tivantinib Oncology
DAIICHI-SANKYO TRIBENZOR Cardiovascular
DAIICHI-SANKYO WELCHOL * Cardiovascular
DAKO OMNIS Medical Device
DART NEUROSCIENCE adarigiline Neurology
DELENEX THERAPEUTICS DELENEX THERAPEUTICS Corporate Identity
DELIVERY TECHNOLOGIES MORPHABOND * Pain & Inflammation
DENDREON ACI Class Name
DENDREON lapuleucel-t Oncology
DENDREON PROVENGE Oncology
DENDREON sipuleucel-t Oncology
DEPOMED GRALISE Pain & Inflammation
DERMA SCIENCES aclerastide Dermatology
DERMIK LABORATORIES BENZACLIN Dermatology
DERMIK LABORATORIES CARAC Dermatology
DERMIK LABORATORIES PENLAC * Antifungal
DERMIRA ATMOS-1 Clinical Trial Name
DERMIRA ATMOS-2 Clinical Trial Name
DERMIRA CIMPACT Clinical Trial Name
DERMIRA CIMPASI-1 Clinical Trial Name
DERMIRA CIMPASI-2 Clinical Trial Name
DERMIRA olumacostat glasaretil Dermatology
DERMIRA QBREXZA * Dermatology
DISCOVERY LABS SURFAXIN Respiratory
DJO GLOBAL MOVATION Medical Device
DNATRIX THERAPEUTICS tasadenoturev Oncology
DOMPE ALLOGENEIC TRANSPLANTATION Clinical Trial Name
DOMPE AUTOLOGOUS TRANSPLANTATION Clinical Trial Name
DOMPE OXERVATE Ophthalmology
DOMPE REPARO Clinical Trial Name
DOUGLAS PHARMS MYORISAN * Dermatology
DOUGLAS PHARMS VERSACLOZ * Neurology
DOW PHARMACEUTICAL SCIENCES ACANYA Dermatology
DOW PHARMACEUTICAL SCIENCES efinaconazole Antifungal
DR. FALK PHARMA JORVEZA Gastrointestinal
DR. REDDY'S LAB AIMI Technology Name
DR. REDDY'S LAB MINOLIRA * Dermatology
DRAGER PERSEUS Medical Device
DUCHESNAY BONJESTA Gastrointestinal
DUCHESNAY MICTORYL * Nephrology
DUCHESNAY MICTORYL PEDIATRIC * Nephrology
DURATA THERAPEUTICS DALVANCE * Antibiotic
DURATA THERAPEUTICS XYDALBA * Antibiotic
DYAX lanadelumab Pain & Inflammation
DYNAVAX TECHNOLOGIES HEPLISAV-B * Vaccine


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top